Actively Recruiting
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Led by Institute of Oncology Ljubljana · Updated on 2026-02-18
130
Participants Needed
1
Research Sites
255 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.
CONDITIONS
Official Title
Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)
- Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C
- Adequate health status for neoadjuvant systemic treatment
You will not qualify if you...
- Inflammatory breast cancer stage IV
- Luminal A, luminal B subtypes of non-inflammatory breast cancer
- Stages I-IIA breast cancer
- Inability to understand or communicate in Slovenian
- Inability to follow protocol instructions
- Inappropriate health status for chemotherapy treatment
- Primary treatment with surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Oncology Ljubljana
Ljubljana, Slovenia, 1000
Actively Recruiting
Research Team
K
Klavdija Korošec
CONTACT
N
Neza Gros
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here